pentobarbital will lessen the extent or outcome of mavacamten by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital decreases levels of toremifene by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. CYP3A4 inducers maximize amount of toremifene metabolism, decreasing the constant-… Read More